The global aortic aneurysm devices market was valued at USD 3.46 billion in 2024 and is forecast to grow at a CAGR of 9.3% from 2025 to 2034. A segmentation-focused review reveals how product differentiation, application-specific growth, value chain optimization, and segment-wise performance are reshaping the competitive landscape across stent grafts, catheters, and procedural types including EVAR and open repair.

By product, stent grafts commanded the largest revenue share in 2024, reflecting their standard role in both thoracic and abdominal aneurysm repair. Catheter systems represent a growing subsegment, buoyed by delivery innovation and integration with imaging modalities. Advanced stent graft design, including fenestrated and branched configurations, illustrates product differentiation tailored for complex anatomies.

By treatment type, endovascular aneurysm repair (EVAR) dominated at ~75% of market value in 2024, outpacing open surgical repair due to shorter hospital stays, lower complication rates, and lower overall cost profiling. As EVAR expands, procedural adoption is shifting from traditional hospitals to ambulatory surgery centers, reflecting application-specific growth and enhancements in value chain optimization.

End-use trends indicate hospitals still perform the bulk of repairs; however, ambulatory surgery centers and specialized vascular clinics are rapidly expanding their share as minimally invasive procedures become more routine. This shift supports value chain optimization by reducing overhead and enhancing throughput in high-volume centers.

Read More @ https://www.polarismarketresearch.com/industry-analysis/aortic-aneurysm-devices-market

Market dynamics show drivers including technological innovation in graft materials, increasingly reliable imaging support, and the shift to minimally invasive procedures. Restraints include regulatory complexity for advanced devices and high upfront costs for device systems. Opportunities exist in segment-wise performance improvement via next-gen graft technology, bundled EVAR procedural pricing models, and catheter system licensing partnerships. Trends include integrated product-service offerings, image-guided device delivery, and increased EVAR penetration through clinic-based models.

Competitive landscape (top market holders):

• Medtronic plc
• W. L. Gore & Associates, Inc.
• Cook Medical, Inc.
• Endologix LLC
• Terumo Corporation

These firms dominate through deep portfolios across device and treatment types, supporting product differentiation and segment-wise performance leadership.

More Trending Latest Reports By Polaris Market Research:

Enterprise Governance, Risk & Compliance Market

Regenerative Agriculture Market

Mice Model Market

Digital Health Market

Surfboard Market

Fraise Mowers Market

Animal Sedatives Market

Coronary Stent Market

Manga Market